Skip to main content
. 2023 Aug 16;24(16):12866. doi: 10.3390/ijms241612866

Figure 1.

Figure 1

Cyclic guanosine monophosphate (cGMP) signaling in cardiomyocytes. cGMP signaling is initiated by two pathways: NO-sGC and NPRs. cGMP activates PKG, which subsequently phosphorylates various signaling molecules such as RGS2/4 and titin. cGMP also modulates cAMP and cGMP degradation. cGMP-bound PDE2 increases cAMP-hydrolyzing activity. cGMP competitively binds to PDE3, thereby inhibiting its activity. cGMP enhances cAMP action through PDE3 inhibition.